Granulocytopenia and hemolytic anemia as complications of propylthiouracil therapy.
D000380:Agranulocytosis / Q000139:chemically induced*; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D002648:Child; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D011441:Propylthiouracil / Q000009:adverse effects* / Q000627:therapeutic use
D011441:Propylthiouracil